Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5871_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Pharmaceutical Practice
- •Contributors
- •Preface
- •Acknowledgements
- •About this book
- •The NHS drugs budget
- •The NHS workforce
- •The current and future roles ofpharmacists
- •Introduction
- •The changing role of pharmacy
- •The extended role
- •The profession
- •Pharmacy education
- •Conclusion
- •Introduction
- •Healthcare systems
- •Education of pharmacists
- •Registration as a pharmacist
- •Community pharmacy
- •Hospital pharmacy
- •Conclusion
- •Introduction
- •Defining health and illness
- •Dimensions of health
- •Determinants and models ofhealth
- •Process of illness
- •Health knowledge, beliefs andattitudes
- •Decision analysis andbehavioural decision theory
- •The treatment process
- •Introduction
- •Functions of medicines
- •A societal perspective onrational use of medicines
- •Use of medicines
- •Pharmacies and the pharmacyprofession
- •Outcomes of medical treatment
- •Introduction
- •What is public health pharmacy?
- •Wider determinants of health
- •Lifestyle determinants of health
- •Measuring deprivation
- •Changing habits and lifestyle
- •Conclusion
- •Introduction
- •Types of cost sharingarrangements
- •Protection mechanisms andexemptions
- •Impact of cost sharing on druguse and health outcomes
- •Impact of cost sharing onpatients and healthcareprofessionals
- •The role of communitypharmacies
- •Conclusion
- •Introduction
- •The World Health Organization
- •WHO’s work in essentialmedicines
- •The essential medicinesconcept
- •The Model List of EssentialMedicines
- •The WHO Model Formulary
- •The need for essentialmedicines for children
- •Conclusion
- •Introduction
- •Clinical governance
- •Quality
- •Clinical governance andpharmacy
- •Professional governance andregulation procedures inpharmacy
- •When things go wrong
- •Introduction
- •Human error models
- •Risk management tools
- •Risk to patients in the pharmacysetting
- •Developments in health policy
- •National Patient Safety Agency(NPSA)
- •The risk management process
- •Conclusion
- •Introduction
- •What is continuing professionaldevelopment?
- •CPD cycle
- •Recording CPD
- •Fitness to practise
- •Conclusion
- •Introduction: what is audit?
- •Relationship between practiceresearch, service evaluationand audit
- •Types of audit
- •What is measured in audit?
- •The audit cycle
- •Learning through audit
- •Introduction
- •Morals, values and ethics
- •Ethical theories
- •Principlism and the four ethicalprinciples
- •Principlist ethics and research
- •Morals and law
- •Applied and professional ethics
- •Ethical issues in health care
- •Ethics and pharmacy
- •Conclusion
- •Introduction
- •Assumptions and expectations
- •What is communication?
- •Listening skills
- •Questioning skills
- •A model for guiding thepharmacist–patient interview
- •Patterns of behaviour incommunication
- •Empathy
- •Barriers to communication
- •Confidentiality
- •Special needs
- •Difficult situations in pharmacy
- •Conclusion
- •Introduction
- •What is teamwork?
- •The healthcare team
- •The community healthcare team
- •Role of the pharmacist inteamwork
- •Conclusion
- •Introduction
- •Why keep records?
- •What to record?
- •Barriers to record keeping
- •The future of records
- •The Data Protection Act 1998
- •Confidentiality
- •Records of supply
- •Clinical governance records
- •Consultation records
- •Introduction
- •Independent prescribing
- •Supplementary prescribing
- •Patient group directions
- •Minor ailment schemes
- •Influences on prescribing
- •Clinical governance inprescribing
- •Code of Ethics
- •Introduction
- •The prescribing process
- •Evidence-based medicine
- •Different types of formularies
- •Formulary development
- •Formulary managementsystems
- •Safety, efficacy and economy
- •Pre-marketing studies
- •Post-marketing studies
- •Pharmacoeconomic evaluationof medicines
- •Drug utilization review andevaluation
- •Introduction
- •Extent of use of CAM
- •Reasons for use of CAM
- •Regulation of CAM
- •Pharmacy and provision of CAM
- •Efficacy and safety of CAMapproaches
- •The future for complementarymedicines
- •Introduction
- •Routes of administration
- •Dosage forms
- •Introduction
- •The concept and growth ofself-care
- •Getting information from thepatient
- •Drawing together information
- •Picking up on non-verbal cues
- •Outcomes from the consultation
- •Conclusion
- •Introduction
- •Where does information existand how can it be retrieved?
- •Directory of useful websites
- •Searching the Internet
- •The sequence of information
- •Information services
- •Conclusion
- •Introduction
- •Information required on aprescription
- •Types of prescription forms
- •Routine procedure fordispensing prescriptions
- •Introduction
- •The working environment andprocedures
- •Equipment
- •Manipulative techniques
- •Ingredients
- •Problem solving inextemporaneous dispensing
- •Counting devices
- •Automated dispensing systems
- •Conclusion
- •Introduction
- •Expressions of concentration
- •Calculating quantities from amaster formula
- •Changing concentrations
- •Calculations where quantity ofingredients is too small to weighor measure accurately
- •Solubilities
- •Calculations involving doses
- •Reconstitution and infusion
- •Self-assessment questions
- •Self-assessment answers
- •Introduction
- •Primary and secondarypackaging
- •Packaging materials
- •Closures
- •Collapsible tubes
- •Unit-dose packaging
- •Paper
- •Patient pack dispensing
- •Introduction
- •Standard requirements forlabelling dispensed medicines
- •Additional labellingrequirements
- •Legal requirements in certaincircumstances
- •Errors in labelling
- •Self-assessment questions
- •Self-assessment answers
- •Introduction
- •Sterile product production
- •Premises
- •Environmental control
- •Environmental monitoring
- •Aseptic preparation
- •Testing for sterility
- •Introduction
- •Solutions for oral dosage
- •Solutions for otherpharmaceutical uses
- •Expression of concentration
- •Formulation of solutions
- •Oral syringes
- •Diluents
- •Introduction
- •Pharmaceutical applications ofsuspensions
- •Properties of a goodpharmaceutical suspension
- •Formulation of suspensions
- •The dispensing of suspensions
- •Introduction
- •Pharmaceutical applications ofemulsions
- •Emulsion types
- •Formulation of emulsions
- •Dispensing emulsions
- •Introduction
- •Types of skin preparation
- •Ingredients used in skinpreparations
- •Dispensing of externalpreparations
- •Transdermal delivery systems
- •Introduction
- •Suppository bases
- •Preparation of suppositories
- •Containers for suppositories
- •Shelf life
- •Labelling for suppositories
- •Patient advice
- •Introduction
- •Powders for internal use
- •Powders for external use
- •Introduction
- •Tablets
- •Capsules
- •Other oral unit dosage forms
- •The role of the pharmacist
- •Introduction
- •The inhaled route
- •Inhaled medicines used forasthma and COPD
- •The peak flow meter
- •Types of inhaler device
- •Introduction
- •Administration procedures
- •Products for parenteral use
- •Formulation of parenteralproducts
- •Large-volume parenteralproducts
- •Introduction
- •Anatomy and physiology of theeye
- •Formulation of eye drops
- •Preparation of eye drops
- •Labelling of containers
- •Instillation of eye drops
- •Formulation of eye lotions
- •Formulation of eye ointments
- •Ophthalmic inserts
- •Contact lenses and theirsolutions
- •Contact lenses
- •Hard lens solutions
- •Soft lens solutions
- •Advice to patients
- •Introduction
- •Cancer chemotherapy
- •Classification of drugs used incancer chemotherapy
- •Targeted therapies
- •Dose and schedule ofchemotherapy
- •Occupational exposure risks
- •Provision of a pharmacy-basedchemotherapy preparationservice
- •Administration of cytotoxicmedicines
- •Provision of chemotherapyat home
- •Centralized intravenous additiveservice (CIVAS)
- •Infusion stability and shelf lifeassignment
- •Introduction
- •Provision of nutritional support
- •Indications for TPN
- •Assessment of the patient inhospital
- •The nutrition team
- •Components of a TPNformulation
- •Compounding of TPN and HPNformulations
- •Compounding of HPNformulations by commercialcompanies
- •Potential complications arisingduring compounding andadministration of TPNformulations
- •Addition of medicines to a TPNor HPN bag
- •Administration of TPN/HPNformulations
- •Potential problems for HPNpatents
- •Training for HPN patients
- •Services provided by home-carecompanies
- •The British Parenteral NutritionGroup
- •Introduction to kidney diseaseand dialysis therapy


This page intentionally left blank

Pharmaceutical Practice

For Elsevier
Commissioning Editor: Pauline Graham, Ellen Green
Development Editor: Carole McMurray, Hannah Kenner
Project Manager: Gail Wright
Designer: Stewart Larking
Illustration Manager: Merlyn Harvey
Illustrator: Paul Bernson, Robert Britton

Pharmaceutical Practice
FOURTH EDITION
Edited by
A. J. Winfi eld BPharm PhD MRPharmS
Formerly Chairman, and Visiting Professor, Department of Pharmacy Practice,
Faculty of Pharmacy, Kuwait University, Kuwait
J. A. Rees BPharm MSc PhD Certifi cate in Health Promotion
Senior Lecturer, School of Pharmacy and Pharmaceutical Sciences, The University of
Manchester, Manchester, UK
I. Smith BSc(Hons) ClinDip FHEA MRPharmS
Boots Teacher Practitioner, The University of Manchester, Manchester, UK
Edinburgh London New York Oxford Philadelphia St Louis Sydney Toronto 2009

© 2004, Elsevier Limited. All rights reserved.
© 2009, Elsevier Limited. All rights reserved.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or
otherwise, without the prior permission of the Publishers. Permissions may be sought
directly from Elsevier’s Health Sciences Rights Department, 1600 John F. Kennedy
Boulevard, Suite 1800, Philadelphia, PA 19103-2899, USA: phone: (+1) 215 239 3804;
fax: (+1) 215 239 3805; or, e-mail: healthpermissions@elsevier.com. You may also
complete your request on-line via the Elsevier homepage (http://www.elsevier.com), by
selecting ‘Support and contact’ and then ‘Copyright and Permission’.
Fourth edition 2009
Third edition 2004
Second edition 1998
First edition 1990
ISBN 978-0-443-06906-2
International edition ISBN 978-0-443-06909-3
British Library Cataloguing in Publication Data
A catalogue record for this book is available from the British Library
Library of Congress Cataloging in Publication Data
A catalog record for this book is available from the Library of Congress
Notice
Knowledge and best practice in this fi eld are constantly changing. As new research and
experience broaden our knowledge, changes in practice, treatment and drug therapy
may become necessary or appropriate. Readers are advised to check the most current
information provided (i) on procedures featured or (ii) by the manufacturer of each
product to be administered, to verify the recommended dose or formula, the method
and duration of administration, and contraindications. It is the responsibility of the
practitioner, relying on their own experience and knowledge of the patient, to make
diagnoses, to determine dosages and the best treatment for each individual patient, and
to take all appropriate safety precautions. To the fullest extent of the law, neither the
Publisher nor the Editors assumes any liability for any injury and/or damage to persons
or property arising out of or related to any use of the material contained in this book.
The Publisher
Printed in China

ontent
s
Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
About this book . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xvii
Section 1 Pharmacy practice and society . . . . . . . . . . . . . . . . . . . 1
1 The role of pharmacy in health care . . . . . . . . . . . . . . . . . . . . . . . 3
Christine M. Bond
2 Models of pharmacy practice within healthcare systems . . . . . . . . . . .17
Judith A. Rees
3 Socio-behavioural aspects of health and illness . . . . . . . . . . . . . . . .25
K. Hannes Enlund
4 Socio-behavioural aspects of treatment with medicines . . . . . . . . . . . .41
K. Hannes Enlund
5 Pharmacy and public health . . . . . . . . . . . . . . . . . . . . . . . . . . .53
Roger Walker
6 Types of patient charges for medicines and their impact. . . . . . . . . . . .63
Ellen Schafheutle
7 WHO and the essential medicines concept . . . . . . . . . . . . . . . . . . .71
Marthe M. Everard
Section 2 Governance and good professional pharmaceutical practice . . . 79
8 Clinical governance – an overview. . . . . . . . . . . . . . . . . . . . . . . .81
Simon J. Tweddell
9 Risk management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89
Darren M. Ashcroft
10 Continuing professional development and fi tness to practise . . . . . . . . .95
Raminder Sihota
11 Audit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Janet Krska
12 Ethics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
Richard C. O’Neill
13 Communication skills for the pharmacist . . . . . . . . . . . . . . . . . . . 123
Judith A. Rees and Isobel J. Featherstone
v

Contents
14 Relationship with other members of the healthcare team . . . . . . . . . . 137
Felice S. Groundland
15 Record keeping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
Mary Zargarani
Section 3 Pharmacy prescribing and selection of medicines . . . . . . . . .153
16 Access to medicines and prescribing – introduction . . . . . . . . . . . . . 155
Jason Hall
17 The prescribing process and evidence-based medicine . . . . . . . . . . . 163
Jason Hall
18 Formularies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Janet Krska
19 Drug evaluation and pharmacoeconomics . . . . . . . . . . . . . . . . . . 185
Janet Krska and Dyfrig A. Hughes
20 Complementary/alternative medicine . . . . . . . . . . . . . . . . . . . . . 199
G. Brian Lockwood
21 Routes of administration and dosage forms . . . . . . . . . . . . . . . . . 211
Arthur J. Winfi eld
22 Prescribing for minor ailments . . . . . . . . . . . . . . . . . . . . . . . . . 219
Paul Rutter
23 Information retrieval . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Parastou Donyai
Section 4 Dispensing and related pharmaceutical practice activities . . . . .261
24 The prescription . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263
Ian Smith
25 Dispensing techniques (compounding and
good practice) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275
Judith A. Rees
26 Pharmaceutical calculations . . . . . . . . . . . . . . . . . . . . . . . . . . 287
Ivan O. Edafi ogho and Arthur J. Winfi eld
27 Packaging. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305
Derek G. Chapman
28 Labelling of dispensed medicines . . . . . . . . . . . . . . . . . . . . . . . 315
Judith A. Rees
29 Production of sterile products . . . . . . . . . . . . . . . . . . . . . . . . . 323
Derek G. Chapman
30 Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 337
Arthur J. Winfi eld
vi

Contents
31 Suspensions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 347
Arthur J. Winfi eld
32 Emulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 355
Arthur J. Winfi eld
33 External preparations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 365
Arthur J. Winfi eld
34 Suppositories and pessaries . . . . . . . . . . . . . . . . . . . . . . . . . . 379
Arthur J. Winfi eld
35 Powders and granules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 387
Arthur J. Winfi eld
36 Oral unit dosage forms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 393
Arthur J. Winfi eld
37 Inhaled route . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 399
Peter M. Richards
38 Parenteral products. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 411
Derek G. Chapman
39 Ophthalmic products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 429
R. Michael E. Richards
40 Specialized services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 447
Graham J. Sewell
41 Parenteral nutrition and dialysis . . . . . . . . . . . . . . . . . . . . . . . . 467
Lindsay Harper and Liz Lamerton
42 Radiopharmacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 483
David Graham
43 Storage of medicines and waste disposal. . . . . . . . . . . . . . . . . . . 493
David R. Bethell and Judith A. Rees
44 Communication skills – role of the pharmacist in giving advice
and information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 501
Judith A. Rees
Section 5 Pharmacy services and monitoring the medicine-taking patient . . . 515
45 Collection and delivery services . . . . . . . . . . . . . . . . . . . . . . . . 517
Karen Rice
46 Concordance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 523
Marjorie C. Weiss
47 Monitoring the patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 533
Alison Littlewood
48 Services for vulnerable patients . . . . . . . . . . . . . . . . . . . . . . . . 547
Victoria Crabtree
49 Substance use and misuse. . . . . . . . . . . . . . . . . . . . . . . . . . . 559
Jenny Scott
vii

Contents
Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .577
Appendix 1 Medical abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 579
Megan R. Thomas
Appendix 2 Latin terms and abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . 585
Arthur J. Winfi eld
Appendix 3 Systems of weights and measures . . . . . . . . . . . . . . . . . . . . . . 589
Arthur J. Winfi eld
Appendix 4 Presentation skills . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 591
R. Michael E. Richards and Megan R. Thomas
Appendix 5 Key references and further reading . . . . . . . . . . . . . . . . . . . . . . 599
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 613
viii
Соседние файлы в папке Библиотека им академика М.И. Перельмана
